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Recent studies indicate that next to antibiotic resistance, bacteria are able to subsist
on antibiotics as a carbon source. Here we evaluated the potential of gut bacteria
from healthy human volunteers and zoo animals to subsist on antibiotics. Nine gut
isolates of Escherichia coli and Cellulosimicrobium sp. displayed increases in colony
forming units (CFU) during incubations in minimal medium with only antibiotics added,
i.e., the antibiotic subsistence phenotype. Furthermore, laboratory strains of E. coli and
Pseudomonas putida equipped with the aminoglycoside 3′ phosphotransferase II gene
also displayed the subsistence phenotype on aminoglycosides. In order to address
which endogenous genes could be involved in these subsistence phenotypes, the
broad-range glycosyl-hydrolase inhibiting iminosugar deoxynojirimycin (DNJ) was used.
Addition of DNJ to minimal medium containing glucose showed initial growth retardation
of resistant E. coli, which was rapidly recovered to normal growth. In contrast, addition
of DNJ to minimal medium containing kanamycin arrested resistant E. coli growth,
suggesting that glycosyl-hydrolases were involved in the subsistence phenotype.
However, antibiotic degradation experiments showed no reduction in kanamycin, even
though the number of CFUs increased. Although antibiotic subsistence phenotypes
are readily observed in bacterial species, and are even found in susceptible laboratory
strains carrying standard resistance genes, we conclude there is a discrepancy between
the observed antibiotic subsistence phenotype and actual antibiotic degradation. Based
on these results we can hypothesize that aminoglycoside modifying enzymes might first
inactivate the antibiotic (i.e., by acetylation of amino groups, modification of hydroxyl
groups by adenylation and phosphorylation respectively), before the subsequent action
of catabolic enzymes. Even though we do not dispute that antibiotics could be used
as a single carbon source, our observations show that antibiotic subsistence should
be carefully examined with precise degradation studies, and that its mechanistic basis
remains inconclusive.
Keywords: antibiotic resistance, antibiotic subsistence, antibiotic subsistence phenotype, aminoglycosides,
single carbon source
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INTRODUCTION
Antibiotic resistance is a global health problem, and resistance
is prevalent in bacteria isolated from both human and animal
sources (van den Bogaard and Stobberingh, 2000; Sommer et al.,
2009). Also, other natural habitats, for example soil, represent
a common reservoir of resistance genes (Dantas et al., 2008).
Recent metatranscriptome analyses have revealed that antibiotic
resistance genes are expressed in a broad range of natural habitats,
even in the absence of obvious antibiotic selection pressure
(Versluis et al., 2015). Furthermore, metagenomic studies of
ancient environments have revealed that antibiotic resistance is
a natural phenomenon that predates the anthropogenic selective
pressure of clinical antibiotic use (D’Costa et al., 2011).
It has long been speculated that, for example in
clinically relevant strains, genes conferring resistance to
aminoglycoside antibiotics were derived from organisms
producing aminoglycosides, suggesting that members of
the Actinomycetes could have provided the initial pool of
aminoglycoside resistance genes (Benveniste and Davies, 1973;
Wright, 2007). Aminoglycosides are useful in the treatment
of Gram-negative aerobic bacilli, staphylococci, and other
Gram-positive bacterial infections (Yao and Moellering, 2007).
The initial site of aminoglycoside action is the outer bacterial
membrane, where the cationic antibiotic molecules create ﬁssures
in the outer cell membrane. These ﬁssures result in leakage of
intracellular contents, and enhanced antibiotic uptake. Once
inside the bacterial cell, aminoglycosides inhibit protein synthesis
by binding to the 30S ribosomal subunit (Gonzalez et al., 1998).
Resistance to aminiglycosides is often due to enzymatic
inactivation by acetyltransferases, nucleotidyltransferases and
phosphotransferases. Other resistance mechanisms include loss
of permeability, structural alteration of the ribosomal target and
the presence of eﬄux pumps (Azucena and Mobashery, 2001).
Streptomycin, a representative of aminoglycoside antibiotics
produced naturally by bacteria, has been shown to participate
in microbial survival pathways. These pathways can be deﬁned
as the capacity of bacterial metabolism to modulate antibiotic
resistance (Martinez and Rojo, 2011). This could indicate that
aminoglycosides, apart from inhibiting bacterial growth, could
stimulate the acquisition of aminoglycoside resistance genes. This
can play an important role in the survival of microorganisms, as
indicated for the acetyltransferase involved in aminoglycoside
resistance in Providencia stuartii (Goldberg et al., 1999; Barlow
and Hall, 2002).
Recently a large and diverse group of bacteria from soil,
seawater, and the gut of humans and farm animals were
found to not merely resist the toxic eﬀects of antibiotics, but
also to use antibiotics including aminoglycosides as a single
carbon source. This phenotype is commonly referred to as
“antibiotic subsistence” (Dopazo et al., 1988; Dantas et al.,
2008; Barnhill et al., 2011; Xin et al., 2012). In addition, the
concept of bacteria subsisting on antibiotics has been referred
to as “antibiotic-resistant extremophiles” (Gabani et al., 2012)
or “antibiotrophs” (Woappi et al., 2014) These alternative
terms depict the microorganisms as being able to subsist
under harsh environmental conditions, e.g., elevated antibiotic
concentrations or the use of antibiotics as the sole carbon
source. In disagreement with the accumulating body of literature
supporting the possibility of bacterial subsistence on antibiotics,
Walsh et al. (2013) tested whether soil bacteria could subsist
on antibiotics. As no degradation of antibiotics occurred, Walsh
et al. (2013) concluded that soil bacteria could not utilize
antibiotics (including streptomycin, trimethoprim, penicillin,
and carbapenicillin) as a carbon source.
To date, no genes have been identiﬁed that could enable
bacteria to use antibiotics as a single carbon source, and therefore
the relationship between antibiotic resistance and antibiotic
subsistence remains unclear (Dantas and Sommer, 2012). To this
end, and since the gut microbiota of humans and animals has
been described as a reservoir of antibiotic resistance, we studied
the potential of gut bacteria to display the antibiotic subsistence
phenotype using a range of antibiotics. Almost all of the bacteria
able to subsist on antibiotics grew on an aminoglycoside, and
therefore we focused on aminoglycosides to address mechanistic
aspects of the subsistence phenotype that could be readily
approached using laboratory model organisms.
MATERIALS AND METHODS
Samples and Antibiotics Used
We evaluated the antibiotic subsistence phenotype of bacteria
subsisting on a range of antibiotics: ampicillin, chloramphenicol,
erythromycin, kanamycin, streptomycin and tetracycline
(1mg/ml) (Sigma-Aldrich, Zwijndrecht, The Netherlands). Fecal
samples from two healthy human volunteers and six species of
exotic zoo animals (Burgers’ Zoo – Arnhem, the Netherlands)
with no previous antibiotic administration (6 months) were used
as inocula (Table 1). Fecal samples from zoo animals were taken
by the zookeepers following internal standard regulations. The
samples were collected immediately after defecation into a sterile
container, and then stored at 4◦C (for 0.5–4 h) before being
transferred to –80◦C.
Isolating Bacteria with the Subsistence
Phenotype
Fecal samples (∼200 mg) were suspended in 5 ml of M9minimal
salts medium (Sigma–Aldrich) and centrifuged twice (5 min at
18,400 g) to prevent carry-over of dissolved carbon from the
fecal material. Washed bacterial cells were then suspended in
5 ml of fresh M9 medium, and 50 μl inoculated into 5 ml M9
medium supplemented with 1 mg/ml of a single antibiotic (98–
99% purity) and incubated at 37◦C for 24 h. Then, the cultures
were serially transferred twice to a fresh media with antibiotic,
followed by plating on Luria Broth agar (LB agar), to quantify
the bacterial growth based on enumeration of colony forming
units (CFU) on the LB plates were counted after 8, 24, 48 h
of incubation at 37◦C. The subsistence phenotype criteria was
identiﬁed based on a twofold increase of CFUs over multiple
transfers. A single colony was selected and tested to conﬁrm the
subsistence phenotype. Glucose (1 mg/ml) was used as a positive
control, while M9 medium lacking any carbon source served as
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negative control for growth. All experiments were performed in
duplicate.
Identification of Bacterial Isolates with
the Subsistence Phenotype
Bacteria subsisting on antibiotics were selected for DNA
ampliﬁcation using the 27F and 1492R primers. PCR was
carried out with FastStart Taq DNA polymerase (Roche) in
a reaction mixture containing 10X Fast Taq buﬀer + MgCl2,
dNTPs (10 mM each, Roche), 10 pmol of both primers in a ﬁnal
volume of 49 μl; ﬁnally add the template of DNA (1 μl). For the
ampliﬁcation reaction, after 5 min at 95◦C, 35 identical cycles
(30 s of denaturation at 95◦C, 40 s of annealing at 52◦C, 90 s of
elongation at 72◦C) were followed by a ﬁnal elongation step of
7 min at 72◦C. The ampliﬁed fragments were selected for partial
sequence analysis of the 16S rRNA gene (∼800 bp) using the
1392R primer, and sequences were deposited in GenBank with
accession numbers KT989026, KT989027, KT989028, KT989029,
KT989030, KT989031, KT989032, KT989033, KT989034,
KT989035 (Table 1). Furthermore, all isolates were tested for
their antibiotic resistance phenotype by dilution agar test as
recommended by Clinical and Laboratory Standards Institute
(2014).
Experimental Controls to Differentiate
Between Aminoglycoside Resistance
and the Subsistence Phenotype
In order to diﬀerentiate between antibiotic resistance and
antibiotic subsistence, we used transformants containing a gene
encoding aminoglycoside 3′ phosphotransferase II (APH (3′) II)
(Berg et al., 1975), one of the most common aminoglycoside-
modifying enzymes in prokaryotes, as a control. In detail,
chemically competent cells of two diﬀerent strains of E. coli
(DH5α and TOP10) were transformed by heat-shock with
cloning vectors pRSF-1b (Novagen, Billerica, MA, USA) and
pCR-2.1TOPO (Invitrogen, Carlsbad, CA, USA), respectively,
both containing an APH (3′) II gene. Also, we used Pseudomonas
putida TEC1 transformed with the cloning vector pUTmini-Tn5-
Km1 (de Lorenzo et al., 1990; Leprince et al., 2012). Transformed
and non-transformed strains were tested for their ability to resist
and subsist on the aminoglycoside antibiotics kanamycin and
neomycin using the protocol described above.
Effect of Deoxynojirimycin (DNJ) on the
Aminoglycoside Subsistence Phenotype
To evaluate the involvement of glycosyl hydrolases (GH)
in the subsistence phenotype on aminoglycoside we selected
deoxynojirimycin (DNJ) (Laboratory of Organic Chemistry,
Leiden University, The Netherlands), which is one of the simplest
natural carbohydrate mimics that can competitively inhibit
speciﬁc glycosidic enzymes (Hughes and Rudge, 1994). We
tested the capacity of E. coli (DH5α) transformed with pRSF-
1b plasmid-encoded APH (3′) II gene, to grow on kanamycin or
glucose (1 mg/ml) as a single carbon source in the presence of
DNJ (range of 0.00001–10 mM of DNJ) and monitored growth
for 24 h. All the experiments were performed in triplicate and
used 96-well plates. Growth was measured by OD = 600 nm for
24 h continuously during incubation at 37◦C with agitation at
75 rpm.
Kanamycin Degradation by Escherichia
coli
To investigate kanamycin degradation by E. coli we performed
an LC-MS/MS analysis. The experimental control was carried
out using E. coli (DH5α) with and without cloning vector pRSF-
1b in the presence of kanamycin (99.25% Kanamycin A Sulfate,
EvoPureTM, GENTAUR Netherlands) (1 mg/ml). An aliquot
was taken at 0, 4, 8, 24 h, and analyzed in duplicate using
LC-MS/MS. In detail, the samples were diluted 100 times in
0,065% heptaﬂuorbutyric acid, with an expected concentration
of 10 mg/L. Octamethylkanamycine was added as an internal
standard to the diluted samples at a concentration of 10 mg/L.
Fifty microliter of the diluted sample was injected using a 2690
separations module high-performance liquid chromatography
(HPLC) system (Waters Corporation, USA) coupled to a Quattro
Micro tandem mass detector (Waters-Micromass, Manchester,
UK). For the analysis samples were separated using a Symmetry
C18 (150 mm × 3 mm, 5 μm) chromatographic column from
Waters (Milford, PA, USA) working at 30◦C and at a ﬂow
rate of 0.4 ml/min. The mobile phase was water containing
0.065% heptaﬂuorbutyric acid (A) mixed on a gradient mode
with methanol containing 0.065% heptaﬂuorbutyric acid (B), as
follows: initiated at 100% A, from 100 to 55% A in 5 min,
from 55 to 40% A in 11.5 min, kept isocratic at 60% B for
5 min, from 60% B to 0% B in 1 min for equilibration of
the column (initial conditions). The mass spectrometer was
operated in electrospray positive mode, and data acquisition was
in multiple reactions monitoring mode (MRM). Source settings
were as follows: capillary voltage 2.7 kV, cone voltage 25 V,
source temperature 120◦C, desolvation temperature 400◦C, cone
nitrogen gas ﬂow 60 L/h, desolvation gas ﬂow 600 L/h. Argon
was used as the collision gas at 3.2 × 10−3 mbar. Calibration was
done by means of a calibration curve (0, 2, 5, 10, and 20 mg/L)
in 0.065% heptaﬂuorbutyric acid. Quantiﬁcation of kanamycin
in the samples was done on the calibrators by means of isotope
dilution using octamethylkanamycin. The bacterial culture was
also plated on LB agar for growth assessment (CFU/ml) as
described above.
RESULTS
Gut Bacteria of Human and Zoo Animals
Displayed Subsistence Phenotype
Nine isolates from human and animal fecal samples displayed
subsistence phenotypes when cultivated with a single antibiotic as
the sole carbon source: six on kanamycin, two on streptomycin,
and one isolate displayed the subsistence phenotype on both
erythromycin and kanamycin (Table 1). The subsistence
phenotype was measured by plating and counting CFU increases,
with a twofold increase of CFUs used to identify the phenotype.
The isolates were classiﬁed by partial sequence analysis of
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TABLE 1 | Human and zoo animal fecal isolates with subsistence phenotype on antibiotics.
Isolate (% 16S rRNA gene identity) Source (Latin name) Resistant to∗ Subsisting on∗ Accession number
Escherichia coli (100) Human 1 (Homo sapiens) AMP, TET, E, KAN, STR STR KT989026
E. coli (100) Human 2 (Homo sapiens) AMP, TET, KAN, STR, CL KAN KT989027
Cellulosimicrobium sp. (99) Chimpanzee (Pan troglodytes) AMP, TET KAN, STR KAN KT989030
Cellulosimicrobium sp. (100) Chimpanzee (Pan troglodytes) AMP, TET KAN, STR STR KT989029
E. coli (100) Baringo giraffe (Giraffe camelopardalis rothschildi) TET, KAN, STR KAN KT989033
E. coli (100) Asian elephant (Elephas maximus) AMP, TET, E, KAN, STR KAN KT989034
Escherichia coli (100) Malayan sun bear(Ursus malayanus) KAN, STR KAN KT989035
E. coli (100) Sumatran tiger (Panthera tigris sumatrae) AMP, TET, E, KAN, STR KAN, E KT989032
Cellulosimicrobium sp. (99) Warthog (Phacochoerus africanus) AMP, KAN, STR KAN KT989028
Agent abbreviation*: AMP, Ampicillin; TET, Tetracycline; E, Erythromycin; KAN, Kanamycin; STR, Streptomycin; and CL, Chloramphenicol.
TABLE 2 | Growth experiments (48 h, performed in duplicate) of
non-resistant and resistant E. coli and P. putida strains on media
containing no carbon source, glucose, or aminoglycosides (kanamycin,
neomycin) in M9 minimal salts medium.
M9 M9 + Glucose
1 mg/ml
M9 +
Kanamycin
1 mg/ml
M9 +
Neomycin
1 mg/ml
Escherichia coli
DH5α – + – –
DH5α + pRSF-1b – + + +
DH5α + pCR-2.1
TOPO
– + + +
TOP10 – + – –
TOP10 + pRSF-1b – + + +
TOP10 + pCR-2.1
TOPO
– + + +
Pseudomonas
putida
TEC1 – + – –
TEC1 +
pUTmini-Tn5-Km1
– + + +
Gray highlighted boxes indicate strains showing subsisting phenotype on
aminoglycosides. The + indicates growth, – indicates no growth.
16S rRNA genes, and seven isolates were identiﬁed as E. coli
and three as Cellulosimicrobium sp. The Cellulosimicrobium
sp. are members of the family Promicromonosporaceae
within the Actinobacteria, and were most closely related to
Cellulosimicrobium cellulans and C. funkei (Table 1), which are
all related to human pathogens (Funke et al., 1995; Kaper et al.,
2004; Petkar et al., 2011). All nine isolates were resistant to two or
more of the following antibiotics: ampicillin, chloramphenicol,
tetracycline, erythromycin, streptomycin, and kanamycin
(Table 1).
Experimental Controls to Differentiate
Aminoglycoside Resistance and
Subsistence Phenotype
Since nine isolates displayed the subsistence phenotype
on aminoglycosides, mainly kanamycin, we included an
experimental control in an attempt to diﬀerentiate between
antibiotic resistance and antibiotic subsistence. This was
performed by equipping laboratory strains with a plasmid-
encoded APH (3′) II gene. All transformants of E. coli and
P. putida, but none of the non-transformed strains, displayed the
subsistence phenotype on kanamycin and neomycin (Table 2).
Growth of the strains on glucose was similar to that in the
presence of aminoglycosides, whereas no growth was observed
in M9 medium to which no carbon source was added (Table 2).
Effect of Deoxynojirimycin on the
Aminoglycoside Subsistence Phenotype
In order to evaluate the involvement of GH in the subsistence
phenotype on aminoglycoside, we tested the capacity of E. coli
(DH5α) transformed with pRSF-1b plasmid- encoded APH (3′) II
gene to grow on kanamycin or glucose as a single carbon source in
the presence of DNJ (range of 0.00001–10 mM). Cultivability was
measured by plating and counting CFUs during 24 h. We found
that in the presence of DNJ and glucose, the bacteria showed
initial growth retardation which was then rapidly overcome
(Figure 1A). In contrast, adding DNJ to a minimal medium
containing only kanamycin as a carbon source arrested growth
completely. This suggested that glycosyl-hydrolases are required
for the subsistence phenotype on kanamycin (Figure 1B).
Kanamycin Degradation by Escherichia
coli
Finally, we studied kanamycin degradation by E. coli (DH5α)
in the presence or absence of the plasmid encoded APH (3) II
gene using 1 mg/ml of high purity kanamycin (Evopure, 99.25%)
in M9 medium. Bacterial growth was calculated using the plate
counting method, and kanamycin was measured by LC-MS/MS.
It was observed that the number of CFUs increased during the
ﬁrst 8 h, although no degradation of the antibiotic was observed
(Table 3).
DISCUSSION
We observed that two groups of bacteria, E. coli and
Cellulosimicrobium sp., present in the gut microbiota of healthy
human volunteers and zoo animals, displayed the subsistence
phenotype on aminoglycosides and erythromycin as a single
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FIGURE 1 | Growth dynamics (in triplicate) of transformed E. coli in M9
medium containing glucose (1 mg/ml) (A) and kanamycin (B) in the
presence of different concentrations of DNJ (in mM).
carbon source. The subsistence phenotype was deﬁned as an
increase of CFUs over multiple transfers compared to the
inoculum incubated in the same media without a carbon
source. In order to avoid the presence of residual carbon
sources, we included a pre-washing step to prevent carry-over
of dissolved carbon from the fecal material and used new
sterile glass material and freshly prepared media. In addition,
we included serial two-fold dilutions of glucose and kanamycin
(1–0.0625 mg/ml) and observed the subsistence phenotype at
all antibiotic concentrations including those more similar to
amounts found in natural habitats (Trieu-Cuot and Courvalin,
1986; data not shown).
Subsistence phenotypes were found previously in
P. fluorescens isolates obtained from lake sediments, which
were described to utilize benzylpenicillin as a carbon, nitrogen
and energy source (Johnsen, 1977). Soil bacteria from the
orders Pseudomonadales and Burkholderiales have also been
isolated based on their capacity to grow on a range of antibiotics
as a single carbon source (Dantas et al., 2008). In another
environment including clinical and non-clinical samples,
Barnhill et al. (2011) observed that multi-resistant Salmonella
spp. were also able to subsist on antibiotics, highlighting the
potential prevalence of the antibiotic subsistence phenotype in a
clinical context. Xin et al. (2012) showed that twomembers of the
Enterobacteria group (e.g.,Klebsiella pneumoniae and Escherichia
fergusonii) isolated from fecal material of healthy volunteers
were able to subsist and bio-degraded chloramphenicol as a
sole carbon source. However, all the strains in the study were
chloramphenicol susceptible, which indicates that the subsistence
and resistance mechanisms were independent in this particular
case.
In our study, since the majority of the bacteria seemed
to subsist on aminoglycosides, we studied laboratory strains
of E. coli and P. putida with a plasmid-encoded APH (3′)
II gene in order to diﬀerentiate aminoglycoside resistance
and the subsistence phenotype. Our results showed that a
common resistance gene facilitates the subsistence phenotype
on aminoglycosides, and these results indicated that resistance
and subsistence mechanism might be linked. Similar subsistence
phenotypes were obtained with P. putida TEC1 using the
cloning vector pUTmini-Tn5-Km1 (de Lorenzo et al., 1990;
Leprince et al., 2012), which similarly contains an APH (3′) II
gene.
Previous studies have shown that kanamycin is stable
under culture conditions for at least a week (Ryan et al.,
1970). Stability has been attributed to its structure where a
six-aminocyclitol ring is attached to aminosugar side chains
through glycosidic bonds. We hypothesized that an intrinsic
metabolic capacity to break down and utilize phosphorylated
aminoglycosides is present in various bacteria. In the genomes
of E. coli and P. putida a multitude of genes predicted to
encode GH exist (40–50 in E. coli and 26 in P. putida), with
typically between 20 and 22 GH gene families annotated in
E. coli. The encoded enzymes could potentially be involved in
breaking the glycosidic bonds in the aminoglycosides, releasing
an accessible carbon source. Due to the large number of
GH encoding genes though single and combinatorial gene
knockouts would not be numerically feasible. It is also likely
that this approach may not deliver the necessary result
due to potential functional redundancy of these enzymes.
TABLE 3 | Concentration of kanamycin and colony forming units (CFUs) obtained in M9 minimal media with kanamycin (EvoPureTM-1 mg/ml) with and
without resistant E. coli during LC-MS/MS experiments over time.
Samples Kanamycin concentration (mg/L) CFU (ml)
Time (Hours) 0 4 8 24 0 4 8 24
MM + KAN 978 1021 1066 1399 – – – –
MM + Ec + KAN 923 977 1005 1306 6.6E + 07 5.4E + 07 5.4E + 07 4.0E + 07
MM + Ec-p + KAN 907 984 1008 1266 4.2E + 07 6.8E + 07 2.2E + 08 1.1E + 09
MM, minimal media; KAN, Kanamycin; Ec, Escherichia coli; Ec-p, Escherichia coli-plasmid encoding aminoglycoside 3′ phosphotransferase II gene.
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In our study we showed that a speciﬁc glycosyl-hydrolase
inhibiting iminosugar (DNJ) abolishes the subsistence phenotype
on aminoglycosides. This suggests that glycosyl-hydrolase
activity could be necessary for the hydrolysis of the glycosidic
bond and subsequent release of the aminosugars from the
aminoglycoside, and hence indicates an involvement of GH in the
antibiotic subsistence phenotype.
Since we found several indications of aminoglycoside
subsistence phenotypes in line with previous observations, we
applied the LC-MS/MSmethod to study kanamycin degradation.
However, no degradation of kanamycin was observed in our
study. Our ﬁndings thus align with the previous observations by
Walsh et al. (2013) suggesting that due to the lack of antibiotic
degradation, the subsistence phenotype cannot be linked to the
use of the antibiotic as a sole carbon source.
So far, no genes have been identiﬁed in the catabolic pathways
of Kanamycin (http://www.ebi.ac.uk/chebi/chebiOntology.do?
chebiId=CHEBI:6104). However, Stancu and Grifoll (2011),
showed that several groups of Gram-positive and Gram-
negative bacteria (including members of the Enterobacteriaceae
family), displayed particular metabolic capabilities such as
hydrocarbon degradation since these were able to grow
on Poeni crude oil as a single carbon source. In addition,
they show that Gram-negative bacteria possessed between
two and four catabolic genes involved in degradation of
saturated, monoaromatic, and polyaromatic hydrocarbons.
Interestingly, these groups of bacteria were resistant to
hydrophilic antibiotics such as ampicillin and kanamycin, and
cellular and molecular modiﬁcations were induced by the
antibiotic.
Since subsistence phenotypes on a range of antibiotics are
readily observed, it is possible that antibiotic resistance genes
frequently allow not only resistance, but also simultaneously
facilitate antibiotic subsistence. Dantas and Sommer (2012)
investigated the connection between subsistomes and resistomes,
and indicated that thus far not a single gene involved in
antibiotic subsistence has been identiﬁed. Although active
aminoglycoside eﬄux pumps have been observed in E. coli
(Mingeot-Leclercq et al., 1999), it is hypothesized that
this mechanism is not actively involved in the E. coli
clones subsisting on the antibiotics. This is because such
activity would hinder accumulation of the drugs in the
cytoplasm, where they are required for catabolism to
occur.
Another potential subsistence mechanism that we
considered was ribosomal protein mutations in spontaneous
kanamycin resistant E. coli strains. It has been indicated
that resistance to kanamycin and neomycin by ribosomal
protein mutation is uncommon since this antibiotic
binds to multiple sites on 30S and 50S ribosomal
subunits, and high level resistance cannot be achieved
by a single mutation (Kucers et al., 1997). However,
aminoglycoside modifying enzymes encoded by plasmids
including the acetyltransferases, adenyltransferases, and
phosphotransferases encoded by plasmids (Neu, 1992)
may inactivate antibiotics (i.e., by acetylation of amino
groups, adenylation and phosphorylation of hydroxyl
groups), before the subsequent action of the catabolic
enzymes.
Based on our results we conclude that gut bacteria isolated
were not able to degrade kanamycin and utilize it as a carbon
source. Nevertheless, we observed that the presence of an
aminoglycoside resistance gene supports the aminoglycoside
subsistence phenotype, and GH seem to be required. This
could indicate a possible link between the resistance and the
subsistence phenotype. In addition, as we only tested one type
of aminoglycoside modifying enzyme, we cannot assume that
all the aminoglycoside modifying enzymes act in the same
way. The diﬀerent mechanisms of enzymatic modiﬁcation could
have diﬀerent consequences. Further studies of kanamycin
degradation linked to the evaluation of the subsistence phenotype
and other aminoglycoside modifying enzymes may therefore
provide further insight to the underlying subsistence mechanism.
Bacteria need to adapt to the growth medium in order to
be able to metabolize the nutrients, and during the lag phase
they are not completely inactive. They grow in size and develop
primary metabolites (such as proteins, enzymes, and RNA) as
well as coenzymes and division factors required for making
new cells. These factors together with the mechanisms involved
in antibiotic resistance could also be hypothesized to facilitate
the antibiotic subsistence phenotype. It also may well be that
bacteria simply need to be resistant to the antimicrobial in
order to be able to exploit trace levels of non-toxic breakdown
products. Future analyses including experimental evolution of
antibiotic subsistence will help to further unravel the possible
mechanisms involved in this phenotype. Nevertheless, since
we were able to identify a bacterial strain that displayed the
subsisting phenotype with both aminoglycoside (kanamycin)
and macrolide (erythromycin) antibiotics, expansion of future
studies to include resistance genes and metabolic pathways
of macrolides as well as aminoglycosides could be of special
interest.
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